To determine if the production of IL-18 by macrophages after HSV-1 infection was due to canonical inflammasome activation, M1 MDMs were treated with VX-765, a caspase-1 specific inhibitor [33–35], prior to either infection with HSV-1 or treatment with nigericin and LPS. This evidence concerns the gene CASP1 and infection.